ea0016p395 | Neuroendocrinology | ECE2008
Pivonello Rosario
, de Herder Wouter W
, Ferone Diego
, Kros Johan M
, De Caro Maria Laura Del Basso
, Lombardi Gaetano
, Colao Annamaria
, Hofland Leo J
, Lamberts Steven WJ
Dopamine receptors (DR) are expressed in the majority of corticotroph pituitary tumors and the dopamine agonist cabergoline is effective in controlling cortisol hypersecretion in around 50% of patients with Cushings disease (CD). In order to characterize the tumors expressing D2 receptors and the profile of patients which might respond to the treatment with D2 agonists, the current study has the aim to correlate D2 receptor expression and...